Tumor Necrosis Correlates with PD-L1 and PD-1 Expression in Lung Adenocarcinoma

被引：0

作者：

Moldvay, J. ^{[1
]}

Teglasi, V. ^{[2
]}

Pipek, O. ^{[3
]}

Rojko, L. ^{[4
]}

Glasz, T. ^{[2
]}

Vagvolgyi, A. ^{[4
]}

Kovalszky, I. ^{[2
]}

Gyulai, M. ^{[5
]}

Lohinai, Z. ^{[4
]}

Raso, E. ^{[2
]}

Timar, J. ^{[2
]}

Dome, B. ^{[4
]}

Szallasi, Z. ^{[2
]}

Reiniger, L. ^{[2
]}

机构：

[1] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary

[2] Semmelweis Univ, Budapest, Hungary

[3] Elte, Budapest, Hungary

[4] Natl Koranyi Inst Pulmonol, Budapest, Hungary

[5] Cty Hosp Pulmonol, Torokbalint, Hungary

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

PD-L1; lepidic growth pattern; tumor necrosis;

D O I：

10.1016/j.jtho.2019.08.1053

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.09-24

引用

页码：S505 / S505

页数：1

共 50 条

[31] Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
Semra Paydas
Emine Kilic Bagir
Mehmet Ali Deveci
Gulfiliz Gonlusen
Medical Oncology, 2016, 33
[32] A snapshot of the PD-1/PD-L1 pathway
Ghosh, Chinmoy
Luong, Gary
Sun, Yue
JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
[33] PD-1 and PD-L1 expression in bone and soft tissue sarcomas
Torabi, Alireza
Amaya, Clarissa N.
Wians, Frank H., Jr.
Bryan, Brad A.
PATHOLOGY, 2017, 49 (05) : 506 - 513
[34] Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
Paydas, Semra
Bagir, Emine Kilic
Deveci, Mehmet Ali
Gonlusen, Gulfiliz
MEDICAL ONCOLOGY, 2016, 33 (08)
[35] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Tremblay-LeMay, Rosemarie
Rastgoo, Nasrin
Chang, Hong
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
[36] Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
Hashimoto, Kazuhiko
Nishimura, Shunji
Akagi, Masao
DIAGNOSTICS, 2020, 10 (08)
[37] PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
Goebel, Holger H.
Distel, Luitpold V. R.
Aigner, Thomas
Buettner-Herold, Maike J.
Grabenbauer, Gerhard G.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 34 : 90 - 98
[38] PD-1/PD-L1 in cardiovascular disease
Sun, YunFeng
Li, Liang
Wu, YaWei
Yang, KePing
CLINICA CHIMICA ACTA, 2020, 505 : 26 - 30
[39] PD-1 and PD-L1 antibodies for melanoma
Tsai, Katy K.
Zarzoso, Ines
Daud, Adil I.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3111 - 3116
[40] CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
Gao, Feng
Chen, Jing
Wang, Jia
Li, Peixiang
Wu, Sheng
Wang, Jue
Ji, Yong
BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2019, 20

← 1 2 3 4 5 →